‘Undruggable’ cancer proteins meet their match

People with a deadly form of pancreatic cancer survive longer on a drug that blocks mutant proteins. The drug targets a family of mutant proteins, improving survival rates. This breakthrough may lead to new treatments for pancreatic cancer.